Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
CELG
Celgene Corp
CELG
|
+$391M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$389M |
| 4 |
GE Aerospace
GE
|
+$378M |
| 5 |
Johnson & Johnson
JNJ
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$307M |
| 2 |
Costco
COST
|
+$279M |
| 3 |
Lowe's Companies
LOW
|
+$273M |
| 4 |
Microsoft
MSFT
|
+$230M |
| 5 |
Chevron
CVX
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Technology | 14.11% |
| 3 | Financials | 10.92% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Real Estate | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Antero Resources
AR
$11.5B
| $34.9M | 0.03% |
6,312,201
+5,132,465
| +435% | +$37M |
|
652
Stratasys
SSYS
$767M
| $34.9M | 0.03% |
1,187,432
-14,966
| -1% | -$355K |
|
653
Methanex
MEOH
$4.17B
| $34.8M | 0.03% |
765,548
+266,200
| +53% | +$13.4M |
|
654
Adeia
ADEA
$3.1B
| $34.8M | 0.03% |
6,380,315
+3,039,120
| +91% | +$18.3M |
|
655
Qualys
QLYS
$6.47B
| $34.7M | 0.03% |
398,900
-230,000
| -37% | -$19.8M |
|
656
Adient
ADNT
$1.44B
| $34.7M | 0.03% |
1,430,700
+544,700
| +61% | +$11.2M |
|
657
Radware
RDWR
$1.22B
| $34.7M | 0.03% |
1,404,100
-24,300
| -2% | -$607K |
|
|
NFBK
658
DELISTED
Northfield Bancorp
NFBK
| $34.7M | 0.03% |
2,224,168
+21,350
| +1% | +$319K |
|
659
Altria Group
MO
$107B
| $34.7M | 0.03% |
+733,000
| New | +$38.4M |
|
660
Canadian Pacific Kansas City
CP
$81.5B
| $34.6M | 0.03% |
735,500
-597,000
| -45% | -$26.7M |
|
661
Viasat
VSAT
$12B
| $34.6M | 0.03% |
428,293
+354,400
| +480% | +$31M |
|
662
Adtran
ADTN
$665M
| $34.6M | 0.03% |
2,265,928
+328,900
| +17% | +$5.25M |
|
663
FMC
FMC
$1.28B
| $34.5M | 0.03% |
+415,900
| New | +$32.6M |
|
|
XEC
664
DELISTED
CIMAREX ENERGY CO
XEC
| $34.5M | 0.03% |
580,932
+210,335
| +57% | +$13.5M |
|
665
Grupo Aeroportuario Centro Norte
OMAB
$5.28B
| $34.4M | 0.03% |
704,500
+21,300
| +3% | +$1.05M |
|
666
Exponent
EXPO
$3.22B
| $34.4M | 0.03% |
587,600
-135,300
| -19% | -$7.7M |
|
667
McGrath RentCorp
MGRC
$2.94B
| $34.4M | 0.03% |
552,995
-27,700
| -5% | -$1.66M |
|
668
Ametek
AME
$59.3B
| $34.2M | 0.03% |
+376,150
| New | +$32.2M |
|
669
Silgan Holdings
SLGN
$4.3B
| $34M | 0.03% |
1,110,280
+720,400
| +185% | +$21.5M |
|
670
Snap
SNAP
$8.79B
| $34M | 0.03% |
2,375,000
+2,099,200
| +761% | +$25.7M |
|
671
Bank of Montreal
BMO
$129B
| $33.9M | 0.03% |
448,950
-135,500
| -23% | -$10.4M |
|
672
Middlesex Water
MSEX
$1.1B
| $33.6M | 0.03% |
567,900
-21,900
| -4% | -$1.27M |
|
|
BSTC
673
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $33.6M | 0.03% |
563,207
-9,340
| -2% | -$588K |
|
674
AppFolio
APPF
$6.97B
| $33.5M | 0.03% |
327,894
-120,700
| -27% | -$11.4M |
|
675
Rush Enterprises Class A
RUSHA
$9.41B
| $33.5M | 0.03% |
2,062,751
+183,825
| +10% | +$3.21M |
|
Similar funds
Jim Simons's Q2 2019 Portfolio in Review
As of Q2 2019, Jim Simons held 3,913 positions worth $114B, up 3.3% from $110B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Jim Simons's Q2 2019 filing shows 495 new, 1,847 increased, 1,145 reduced and 397 closed positions. Its largest new stake was Apple: 9,290,160 shares worth $460M. The largest sale was UnitedHealth, an estimated $307M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Jim Simons's largest Q2 2019 buy was Apple: 9,290,160 shares worth $460M.
- Jim Simons added most to Celgene Corp in Q2 2019, an estimated $391M increase.
- Jim Simons's biggest Q2 2019 reduction was Microsoft, cutting an estimated $230M.
- Jim Simons fully exited UnitedHealth in Q2 2019, selling an estimated $307M.
- Jim Simons's ten largest holdings make up 9.1% of its $114B portfolio in Q2 2019.
- Jim Simons opened 495 new positions and closed 397 in Q2 2019.
- Jim Simons's portfolio value rose 3.3% quarter-over-quarter to $114B.
Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.